RPL7 Antikörper (C-Term)
Kurzübersicht für RPL7 Antikörper (C-Term) (ABIN1931770)
Target
Alle RPL7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 200-248, C-Term
-
Spezifität
- Region between residue 200 and the C-terminus (residue 248) of human Ribosomal Protein L7 using the numbering given in entry NP_000962.2 (GeneID 6129).
-
Aufreinigung
- Immunoaffinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
Approved: IF (1:100 - 1:500), IHC, IHC-P (1:200 - 1:1000), IP (2 - 5 μg/mg lysate), WB (1:2000 - 1:10000)
Usage: Immunohistochemistry: Antigen retrieval with Tris-EDTA pH 9.0 is recommended for FFPE tissue sections. Human controls: Breast Carcinoma, Non-Small Cell Lung Cancer, Prostate Carcinoma IHC MOUSE CONTROLS Colon Carcinoma CT26, Renal Cell Carcinoma, Teratoma. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Tris-buffered saline, 0.1 % BSA, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C for up to 1 year.
-
Haltbarkeit
- 12 months
-
-
- RPL7 (Ribosomal Protein L7 (RPL7))
-
Andere Bezeichnung
- RPL7 / L7
-
Hintergrund
-
Name/Gene ID: RPL7
Synonyms: RPL7, 60S ribosomal protein L7, HumL7-1, L7, Ribosomal protein L7 -
Gen-ID
- 6129
Target
-